MULTISHIELD DC

국가: 프랑스

언어: 영어

출처: HMA (Heads of Medicines Agencies)

지금 구매하세요

제품 특성 요약 제품 특성 요약 (SPC)
07-04-2013

유효 성분:

neomycin 100 mg, procaine 400 mg

제공처:

Cross Vetpharm Group

ATC 코드:

QJ51RC

약제 형태:

Intramammary suspension

치료 그룹:

lactam antibacterials, penicillins, combinations with other antibacterials

치료 영역:

Cattle Food

승인 날짜:

2012-12-21

제품 특성 요약

                                SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Multishield DC Intramammary Suspension for Cows.
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each 4.5g intramammary syringe contains
Active Substances:
Neomycin
70 000 IU
(corresponding to Neomycin Sulphate
100 mg)
Penethamate
77.2 mg
(corresponding to Penethamate Hydriodide
100 mg)
Benzylpenicillin
227.2 mg
(corresponding to Procaine Benzylpenicillin
400 mg)
Excipients:
For a full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Intramammary suspension.
A smooth, off white, oily suspension.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Cows (at dry off).
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
In cows at drying off:
Treatment of subclinical mastitis caused by bovine mastitis organisms sensitive to the combination of active
substances, penicillin and neomycin, and as part of strategy for the prevention of new infections occurring during the
dry period.
4.3 CONTRAINDICATIONS
Do not use in lactating cows.
Do not use in animals which are known to be hypersensitive to
-lactam antibiotics, cephalosporin antibiotics,
neomycin or other aminoglycoside antibiotics or to iodine.
Do not use in cows with clinical mastitis.
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
IRISH MEDICINES BOARD
________________________________________________________________________________________________________________________
_Date Printed 29/01/2013_
_CRN 7010064_
_page number: 1_
4.5 SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTIONS FOR USE IN ANIMALS
Use of the product should be based on susceptibility testing of the bacteria isolated from the animal. If this is not
possible, therapy should be based on local (regional, farm level) epidemiological information about susceptibility of the
target bacteria.
Official, national and regional antimicrobial p
                                
                                전체 문서 읽기
                                
                            

이 제품과 관련된 검색 알림

문서 기록보기